Skip to content

Down but not out: drugs that enhance delta oscillations but preserve consciousness

Joel Frohlich, Pedro A. M. Mediano, Francesco Bavato, Alireza Gharabaghi

January 30, 2023 preprint DOI: 10.31234/osf.io/tj2sw (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review
Citations 1
Key findings The authors argue that drug challenge studies with antiepileptics, GABA-B-ergics, anticholinergics, and psychedelic tryptamines show a dissociation between neurophysiological 'down' states (diffuse high-amplitude delta EEG resembling cortical down states) and psychological 'out' states (unconsciousness), and propose that some of these substances may be valuable tools for investigating the neural patterns sufficient for consciousness or its absence.

Abstract

Delta (1 – 4 Hz) EEG/MEG activity is generally indicative of loss of consciousness and cortical down states, particularly when it is diffuse and high amplitude. Remarkably, however, drug challenge studies of several diverse classes of pharmacological agents—including antiepileptics, GABA-B-ergics, anticholinergics, and psychedelic tryptamines—demonstrate that participants appear to be neurophysiologically “down” (EEG activity resembling cortical down states) even when they are not psychologically “out” (unconscious). Of those substances that are safe to use in healthy volunteers, some may be highly valuable research tools for investigating which neural activity patterns are sufficient for consciousness or its absence.

Citations in the library

Explore topics